Azadyne Ltd

www.azadyne.com

We are a pharma R&D company dedicated to delivering improved medicines for patients with autoimmune disease, including Multiple Sclerosis. AZADYNE originated from cutting-edge research from the laboratories of Profs Vincent P. Kelly, Stephen Connon and J. Mike Southern of Trinity Biomedical Sciences Institute, Trinity College Dublin. Autoimmunity occurs when the body mistakenly attacks itself resulting in inflammation and damage. Over time this can lead to chronic, debilitating diseases such as Multiple Sclerosis, Rheumatoid Arthritis and Inflammatory Bowel Disease. Currently, these diseases are not curable. Our pioneering approach has identified a naturally occurring micronutrient called queuine with the ability to control autoimmune response in the body. Through novel chemistry and unique insights, AZADYNE has developed new molecules delivering improved therapeutic outcomes for patients and their families. Our candidates are on the path to Phase I or FIH trials.

Read more

Reach decision makers at Azadyne Ltd

Lusha Magic

Free credit every month!

We are a pharma R&D company dedicated to delivering improved medicines for patients with autoimmune disease, including Multiple Sclerosis. AZADYNE originated from cutting-edge research from the laboratories of Profs Vincent P. Kelly, Stephen Connon and J. Mike Southern of Trinity Biomedical Sciences Institute, Trinity College Dublin. Autoimmunity occurs when the body mistakenly attacks itself resulting in inflammation and damage. Over time this can lead to chronic, debilitating diseases such as Multiple Sclerosis, Rheumatoid Arthritis and Inflammatory Bowel Disease. Currently, these diseases are not curable. Our pioneering approach has identified a naturally occurring micronutrient called queuine with the ability to control autoimmune response in the body. Through novel chemistry and unique insights, AZADYNE has developed new molecules delivering improved therapeutic outcomes for patients and their families. Our candidates are on the path to Phase I or FIH trials.

Read more
icon

City (Headquarters)

Canterbury

icon

Employees

1-10

icon

Founded

2016

icon

Social

  • icon
  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Chief Executive Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Chairman

    Email ****** @****.com
    Phone (***) ****-****
  • Non Executive Director

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(6)

Reach decision makers at Azadyne Ltd

Free credits every month!

My account

Sign up now to uncover all the contact details